ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,306.04
0.02%
Dow Jones
38,852.86
-0.55%
US Dollar vs MXN
16.7975
0.01%
Brent Oil
84.125
-0.24%
Bitcoin
68,705.85
0.61%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Trinity Biotech PLC (TRIB)

  7. Trinity Biotech PLC (TRIB) Noticias

TRIB

Trinity Biotech (TRIB)

Trinity Biotech PLC
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:TRIB
FechaHoraFuenteTítuloSímboloCompañía
28/05/202406:55Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
23/05/202407:00GlobeNewswire Inc.Trinity Biotech Announces Q1 2024 Financial Results and Reiterates GuidanceNASDAQ:TRIBTrinity Biotech PLC
16/05/202408:18GlobeNewswire Inc.Trinity Biotech Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAINASDAQ:TRIBTrinity Biotech PLC
13/05/202410:42GlobeNewswire Inc.Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance for 2024 TrinScreen HIV SalesNASDAQ:TRIBTrinity Biotech PLC
08/05/202409:36GlobeNewswire Inc.Trinity Biotech Welcomes Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and DevelopmentNASDAQ:TRIBTrinity Biotech PLC
07/05/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TRIBTrinity Biotech PLC
07/05/202415:25Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TRIBTrinity Biotech PLC
04/04/202406:30GlobeNewswire Inc.Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business UpdatesNASDAQ:TRIBTrinity Biotech PLC
28/03/202417:39GlobeNewswire Inc.Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial ResultsNASDAQ:TRIBTrinity Biotech PLC
08/03/202409:03GlobeNewswire Inc.Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price RuleNASDAQ:TRIBTrinity Biotech PLC
15/02/202411:34GlobeNewswire Inc.Trinity Biotech Plc Finalizes Effective Date of ADS Ratio ChangeNASDAQ:TRIBTrinity Biotech PLC
13/02/202408:00GlobeNewswire Inc.Trinity Biotech Plc Announces Plan to Implement ADS Ratio ChangeNASDAQ:TRIBTrinity Biotech PLC
09/02/202418:51Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:TRIBTrinity Biotech PLC
08/02/202407:30GlobeNewswire Inc.Trinity Biotech to Present at Emerging Growth ConferenceNASDAQ:TRIBTrinity Biotech PLC
07/02/202407:30GlobeNewswire Inc.Trinity Biotech Announces Application for Early Sjogrens Syndrome Test Panel PLA CodeNASDAQ:TRIBTrinity Biotech PLC
31/01/202406:05GlobeNewswire Inc.Trinity Biotech Announces Q3 2023 Financial Results & Business UpdateNASDAQ:TRIBTrinity Biotech PLC
31/01/202406:02GlobeNewswire Inc.Trinity Biotech Announces Entry into a Letter of Intent with Bayer for a Joint Partnership to Launch a CGM Biosensor Device in China and IndiaNASDAQ:TRIBTrinity Biotech PLC
31/01/202406:00GlobeNewswire Inc.Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.NASDAQ:TRIBTrinity Biotech PLC
30/01/202416:23GlobeNewswire Inc.Trinity Biotech plc to Host Investor CallNASDAQ:TRIBTrinity Biotech PLC
02/01/202415:17Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TRIBTrinity Biotech PLC
27/12/202307:57GlobeNewswire Inc.Trinity Biotech Announces It Has Begun Shipments of Its New HIV Screening Test, TrinScreen HIV to KenyaNASDAQ:TRIBTrinity Biotech PLC
18/12/202315:30GlobeNewswire Inc.Trinity Biotech Announces Management ChangesNASDAQ:TRIBTrinity Biotech PLC
28/11/202315:05GlobeNewswire Inc.Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held SharesNASDAQ:TRIBTrinity Biotech PLC
10/10/202307:15GlobeNewswire Inc.Trinity Biotech Welcomes The Decision Of The High Court Of Kenya To Strike Out The Applications To Prevent the Procurement of TrinScreen HIV By The Kenyan Ministry of HealthNASDAQ:TRIBTrinity Biotech PLC
03/10/202308:15GlobeNewswire Inc.Trinity Biotech Announces Q2 2023 Financial ResultsNASDAQ:TRIBTrinity Biotech PLC
03/10/202306:58IH Market NewsTuesday’s Wall Street Highlights: GM, Airbnb, Tesla, Apple, Oddity Tech, and moreNASDAQ:TRIBTrinity Biotech PLC
27/09/202311:50GlobeNewswire Inc.Trinity Biotech plc to Announce Second Quarter Fiscal Year 2023 Financial ResultsNASDAQ:TRIBTrinity Biotech PLC
11/09/202315:50GlobeNewswire Inc.Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Minimum Bid Price RequirementNASDAQ:TRIBTrinity Biotech PLC
07/08/202307:00GlobeNewswire Inc.Trinity Biotech Announces That It Has Received 510(k) Clearance From The U.S. Food and Drug Administration for the Premier Resolution SystemNASDAQ:TRIBTrinity Biotech PLC
06/07/202308:45GlobeNewswire Inc.Trinity Biotech Announces Q1 2023 Financial ResultsNASDAQ:TRIBTrinity Biotech PLC
 Showing the most relevant articles for your search:NASDAQ:TRIB

Su Consulta Reciente

COIN
LDBCUST
LDBC
BITMOT
775435
Total Cap In Tf 1,375% M...
COIN
FADEGBP
BIT
UB2Y6K
UniCredit Bank
LSE
FRG
Firering Strategic Miner...
LSE
0HDK
Systemair Ab
BOV
TUPY3
TUPY ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados